Kronos Bio

+$0.08 (+2.38%) As of 5:33 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kronos Bio and other ETFs, options, and stocks.

About KRON

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic malignancies, prostate cancer, MYC-driven cancers, and small cell/neuroendocrine cancers.

CEO
Norbert W. Bischofberger
Employees
96
Headquarters
San Mateo, California
Founded
2017

KRON Key Statistics

Market cap
195.16M
Price-Earnings ratio
—
Dividend yield
—
Average volume
890.26K
High today
$3.49
Low today
$3.30
Open price
$3.35
Volume
202.35K
52 Week high
$28.42
52 Week low
$3.21

KRON Earnings

-$6.48
-$4.32
-$2.16
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure